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Peritoneal dialysis is a rare cause of pleural effusion. It appears, as a complication of contin-
uous ambulatory peritoneal dialysis (CAPD), in approximately 2% of all CAPD patients.
We describe three patients with pleural effusions secondary to CAPD. Because of the late
onset of pleural effusion and pulmonary symptoms, i.e. months after CAPD treatment was initi-
ated, the pleural effusion was not directly regarded as a complication of CAPD.
After thoracocentesis with biochemical analysis of crystal clear pleural fluid and in two
patients Tc-99 peritoneal scintigraphy/contrast enhanced CT-scanning, which demonstrated
pleuroperitoneal communication, we concluded that pleural effusion was secondary to CAPD
in these three subjects.
All patients were treated with hemodialysis after cessation of CAPD and because two of
them wanted to continue with CAPD, video-assisted thoracoscopic surgery with talc poudrage
(chemical pleurodesis) was performed in order to prevent recurrence.
Pleural effusions secondary to CAPD is not a frequent complication of CAPD though a very
important one because CAPD must be stopped if it appears. Diagnostic thoracentesis (high
glucose concentration) may be the simplest way to make a diagnosis but a contrast enhanced
CT-scanning is essential for diagnosis of bigger diaphragmatic defects.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
The causes of pleural effusion are pulmonary or extrap-
ulmonary diseases.1 The most common cause is congestivetrecht.nl (I. Krivokuca).
ll rights reserved.heart failure.1,2 Pleural effusion is rarely caused by peri-
toneal dialysis. Approximately 2% of all CAPD patients
develop massive transudative pleural effusion.3 CAPD-
related pleural effusion was first described in 1967 and
usually occurs on the right side 4 but sometimes on the left
side or on both sides.1
Possible explanation for the right-sided predominance
is, in case of congenital diaphragmatic defects, coverage of
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dium, which prevents fluid leakage.3 Not all diaphragmatic
defects leading to pleuroperitoneal communications are
congenital. Some of them are acquired, due to high intra-
abdominal pressure.3
In 2003, Tang et al. described a series of CAPD patients
with hydrothorax due to pleuroperitoneal communications.
Hydrothorax developed in this group within 5.8 months
(median, 5.2 months; range 2 days to 11.2 months) after
the start of peritoneal dialysis.5 A hydrothorax did not
develop directly after commencing peritoneal dialysis,
probably because the formation of acquired pleuro-
peritoneal communications takes some time. These
communications develop secondary to high intra-abdominal
pressure due to exchanges of dialysate, which leads to
separation of diaphragmal collagen fibres, pleural bleb
formation and subsequent rupture of the bleb, resulting in
the opening of the pleuroperitoneal communications.6
Case reports
Case A
A 61-year-old man with a history of peritoneal dialysis four
months earlier and CAPD peritonitis with uremic pericarditis,
was admitted to our hospital because of dyspnea at exertion
since one day before admission. He had no fever, cough,
sputum production or chest pain. Physical examination
revealed shortness of breath with a respiratory rate of
30 breaths/min. His body temperature was 37.6 C, his blood
pressurewas 130/80 mmHgand thepulse ratewas 100 beats/
min.Oxygen saturationwas 96%with 3 L of additional oxygen.
There was no jugular venous distension and there were
no signs of congestive heart failure. Decreased breath-
sounds were heard on auscultation at the right side. Cardiac
examination was normal. A chest X-ray demonstrated
a massive right-sided pleural effusion (Fig. 1) Laboratory
evaluation demonstrated pronounced renal dysfunction,
a white-cell count of 6.3 per cubic millimeter and a CRP
value of 132 mg/l. Arterial blood gas analysis revealed a pH
of 7.45, PCO2 was 32 mm Hg, PO2 was 59 mm Hg, bicar-
bonate 21 mmol/l, and a base deficit of 2.8 mmol/l.
Diagnostic thoracentesis revealed crystal clear pleural
fluid with a high glucose concentration of 14 mmol/l. TheFigure 1 a, b Chest radiograph demonstratinpleural-fluid protein was <20 g/L and according to Light’s
criteria the fluid appeared to be a transudate. Cytological
and microbiological examination of the pleural fluid showed
no abnormalities.
Therapeutic thoracentesiswas performed andexcess fluid
was completely removed. Peritoneal dialysiswas temporarily
ceased and converted to hemodialysis. The investigation of
choice, peritoneal scintigraphy, was performed and pleuro-
peritoneal communications were seen at the right side.
Contrast enhanced CT-scanning did not show diaphragmatic
hernias. Subsequently, video-assisted thoracoscopic surgery
with talc poudrage was performed to prevent recurrence of
thepleural fluid. Peritoneal dialysiswas resumeda fewweeks
after the pleurodesis without recurrence of the pleural fluid.
Case B
A 52-year-old female CAPD patient was admitted to our
hospital because of dyspnea at exertion and a vague chest
pain. Her medical history revealed a polycystic kidney
disease and secondary hyperparathyroidism. She was hae-
modynamically stable and not tachypnoeic, she was afebril
and her percutaneous oxygen saturation during room air
breathing was 93%. Breathsounds were decreased on
auscultation at the right side. Her chest radiograph
demonstrated a massive right-sided pleural effusion and
basal atelectasis. Diagnostic thoracentesis revealed
a transparent pleural fluid with a pleural-fluid glucose level
of 6.4 mmol/l. The pleural-fluid protein and LD levels were
very low indicating the pleural fluid to be a transudate.
Because of the relatively low glucose level in the pleural
fluid, peritoneal scintigraphy and contrast enhanced
CT-scanning were performed and a pleuroperitoneal leak of
peritoneal fluid was detected through a Morgagni’s hernia
(Fig. 2). Therapeutic thoracentesis was not performed but
CAPD treatment was stopped and the patient was treated
with hemodialysis for several weeks. The pleural effusion
disappeared but directly after peritoneal dialysis was
restarted, the pleural fluid recurred. Since conservative
treatment failed a video-assisted thoracoscopic talc pleu-
rodesis was performed. At the same time the diaphragmatic
hernia was closed. Three months after this procedure
hemodialysis was converted to peritoneal dialysis and after
one month she had a recurrence of the pleural fluid at theg right-sided pleural effusion in patient A.
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therefore she was again treated with hemodialysis.
Case C
A 30-year-old woman presented with symptoms of dyspnea
and chest pain precipitated by bending. She was treated
already for eleven months with CAPD. Her chest radiograph
showed a right-sided pleural effusion and biochemical anal-
ysisof clearpleuralfluid revealeda lowproteinconcentration
and a high glucose concentration of 14 mmol/l. The serum
glucose concentration was 5 mmol/l and therefore the diag-
nosis was CAPD-related pleural effusion. After termination of
CAPD fluid exchange and conversion to hemodialysis, the
pleural fluid slowly disappeared. Video-assisted thoraco-
scopic surgerywith talc poudragewas notperformedbecause
this patient preferred to continue with hemodialysis.
Discussion
Pleural effusion is an uncommon complication of CAPD and
VATS with talc pleurodesis is a therapeutic option for these
patients as shown in two of our patients (A and B) if they
want to continue CAPD.
It is very important to recapitulate that a hydrothorax
develops not directly after commencing peritoneal dialysis.
So peritoneal dialysis as a cause of a pleural effusion should
be included in the differential diagnosis of a hydrothorax of
CAPD patients, even if it develops several weeks or months
after pleural dialysis was started.
The most frequently used term for diaphragmal fenes-
tration is ‘‘pleuro-peritoneal’’ communication but the flow
of dialysate is unidirectional ‘‘peritoneo-pleural’’. As in
transdiaphragmatic migration of ascites (hepatic hydro-
thorax),9 the fluid flows against the gravity and along
a pressure gradient due to a lower pressure of the pleural
space compared to the peritoneal space.9 Therefore, the
term ‘‘peritoneo-pleural’’ communication would be more
appropriate.
Diagnosis
Diagnostic thoracentesis and pleural-fluid analysis are often
diagnostic, revealing a crystal clear pleural fluid with a low
protein and a high glucose concentration.3,10 The term
‘‘sweet’’ hydrothorax is sometimes used because of this
high glucose concentration.7,8 According to Chow a glucoseFigure 2 Contrast enhanced CT (A transversal, B coronal, C
dialysate. A diaphragmatic hernia of the Morgagni foramen was shgradient (pleural-fluid glucose level minus simultaneous
serum glucose level) of more than 50 mg/dL (2.7 mmol/l)
has a 100% sensitivity and specificity to detect a sweet
hydrothorax,3 but some patients had a lower glucose
gradient, probably secondary to glucose reabsorption by
the pleural mesothelium.5
Analysis of pleural fluid is often sufficient to establish
the diagnosis, but in uncertain cases and when the anatomy
of the diaphragmal communication needs to be demon-
strated, further imaging, such as peritoneal scintigraphy
and contrast CT peritoneography, are required.3
Tc-99m sulfur colloid or contrast material can be injec-
ted into a 2 L dialysate bag and instilled into the peritoneal
cavity followed by periodic imaging at 1/2, 1, 2, and 4 h,
respectively.6
Diaphragmatic defects or blebs can be intraoperatively
identified by intraperitoneal infusion of colored CAPD fluid
or by CO2 inflation (check-air-leakage method).
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Treatment
Discontinuation of peritoneal dialysis
Temporary discontinuation of CAPD, for 1e4 months, as
first-line treatment, and temporary transfer to hemodial-
ysis (HD), is usually indicated. This conservative approach
can be effective in half of cases.
Chemical or surgical pleurodesis
Chemical pleurodesis can be performed, via a chest drain,
with talc, tetracycline, autologous blood and other agents.
This was only successful in 48% of cases.4 A ten-day wait
period after pleurodesis is advised before resuming the
peritoneal dialysis.
Chemical pleurodesis can also be done as talc insuffla-
tion, under video-assisted thoracoscopic guidance. This was
successful in 90% (50e100%) of cases.4 Peritoneal dialysis
can be resumed after 3e4 weeks.3
There are no data about superiority of any of the
mentioned agents for chemical pleurodesis. Systemic
absorption of tetracycline from the pleural space is rapid
and it has a renal clearance, which is a drawback of
tetracycline pleurodesis in this patient group. 4
Adhesions, developed after chemical pleurodesis via
a chest drain, can jeopardise subsequent feasibility of
successful thoracoscopy.3,12
The bigger diaphragmatic defects can be closed during
thoratocomy by suturing and at the same time, pleurodesis
by pleurectomy or pleural abrasion could be performed.3sagittal image) with intraperitoneal infused contrast-mixed
own at the right side.
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phragmatic defects can also be performed by video-assisted
thoracoscopy.3
Conclusion
CAPD is an uncommon cause of pleural effusion and appears
in approximately 2% of all CAPD patients.3 It is an important
complication because CAPD must be stopped. Pleural-fluid
biochemical analysis is usually diagnostic revealing a crystal
clear pleural fluid with a high glucose concentration and
a low protein concentration (‘‘sweet’’ hydrothorax).3,10
If the diagnosis is not clear, imaging should be performed
by either peritoneal scintigraphy or contrast CT peri-
toneography to detect possible peritoneopleural communi-
cations. A conservative approach, which means temporarily
conversion of peritoneal dialysis to hemodialysis for a period
of 1e4 months, is successful in half of cases.
Pleurodesis, preferentially achieved by talc insufflation
under video-assisted thoracoscopic guidance, has a success
rate in excess of 90%. This treatment is safe with a low
recurrence rate and if necessary can be repeated. More-
over, in case diaphragmatic defects exist, these can be
treated at the same time.
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